Population PKPD of voclosporin in renal allograft patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of clinical pharmacology

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jcph.237PMID 24243422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Voclosporin Food Effect and Single Oral Ascending Dose Pharmacokinetic and Pharmacodynamic Studies in Healthy Human Subjects

  2013cited by this paper
• Ablation of Calcineurin Aβ Reveals Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases*

  2012cited by this paper
• The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation

  2011influential reference
• Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.

  2011cited by this paper
• Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.

  2011cited by this paper
• Hospital nurse staffing models and patient and staff-related outcomes.

  2011cited by this paper
• Cell Communication and Signaling BioMed Central

  2009cited by this paper
• Development and validation of a LC/MS/MS method for quantifying the next generation calcineurin inhibitor, voclosporin, in human whole blood.

  2008cited by this paper
• Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function

  2006cited by this paper
• Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function.

  2006cited by this paper
• Immunosuppression: Evolution in Practice and Trends, 1994–2004

  2006cited by this paper
• Body surface area in normal-weight, overweight, and obese adults. A comparison study.

  2006cited by this paper
• Sirolimus in Combination with Tacrolimus Is Associated with Worse Renal Allograft Survival Compared to Mycophenolate Mofetil Combined with Tacrolimus

  2005cited by this paper
• Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.

  2005cited by this paper
• Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR‐1, CYP3A4, and CYP3A5 genes

  2004cited by this paper
• In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates.

  2003cited by this paper
• Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice.

  2003cited by this paper
• Population pharmacokinetics of tacrolimus in adult kidney transplant recipients

  2002cited by this paper
• Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients.

  1995cited by this paper
• Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

  1992cited by this paper
• Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability

  1992cited by this paper
• Simplified calculation of body-surface area.

  1987cited by this paper
• Simplified Calculation of Body-Surface Area

  1987cited by this paper
• Some suggestions for measuring predictive performance

  1981cited by this paper
• Biological Crystallography Structural Basis for the Cyclophilin a Binding Affinity and Immunosuppressive Potency of E-isa247 (voclosporin)

  year unknowncited by this paper

• Dried blood spot LC-MS/MS quantification of voclosporin in renal transplant recipients using volumetric dried blood spot sampling.

  2024cites this paper
• Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis

  2023cites this paper
• Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients

  2023cites this paper
• Systemic calcineurin inhibitors tacrolimus and voclosporin: a review of off-label dermatologic uses.

  2023cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin

  2023influential citation
• Treatment of lupus: more options after a long wait

  2022cites this paper
• Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE

  2021influential citation
• Innovative Trials and New Opportunities in SLE.

  2021cites this paper
• The Evolving Role of Calcineurin Inhibitors in Treating Lupus Nephritis.

  2020cites this paper
• Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview

  2020cites this paper
• Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects

  2019cites this paper
• A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.

  2019cites this paper
• Induction Therapy for Lupus Nephritis: the Highlights

  2018cites this paper
• An evaluation of voclosporin for the treatment of lupus nephritis

  2018cites this paper
• Pediatric lung transplantation and end of life care in cystic fibrosis: Barriers and successful strategies

  2017cites this paper
• comparing the ef fi cacy and safety of dose-ranging voclosporin with p A randomized , controlled double-blind study lacebo in achieving remission in patients with active lupus nephritis

  year unknowncites this paper